Search NASA⌕ Search

SEARCH · Search NASA

Results for “PALLADIUM 124”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

Nuclear Data Sheets for A = 124

The 1997 evaluation for A = 124 mass chain (1997Ii01) has been revised using experimental results from decays and reactions. Adopted values for the level and decay properties are tabulated. Inconsistencies and discrepancies are noted.

73 NUCLEAR PHYSICS AND RADIATION PHYSICS↗

Deformation effects and neutrinoless positron {beta}{beta} decay of {sup 96}Ru, {sup 102}Pd, {sup 106}Cd, {sup 124}Xe, {sup 130}Ba, and {sup 156}Dy isotopes within a mechanism involving Majorana neutrino mass

The ({beta}{sup +}{beta}{sup +}){sub 0{nu}} and ({epsilon}{beta}{sup +}){sub 0{nu}} modes of {sup 96}Ru, {sup 102}Pd, {sup 106}Cd, {sup 124}Xe, {sup 130}Ba, and {sup 156}Dy isotopes are studied in the projected Hartree-Fock-Bogoliubov framework for the 0{sup +}{yields}0{sup +} transition. The reliability of the intrinsic wave functions required to study these decay modes has been established in our earlier works by obtaining an overall agreement between the theoretically calculated spectroscopic properties, namely yrast spectra, reduced B(E2:0{sup +}{yields}2{sup +}) transition probabilities, quadrupole moments Q(2{sup +}) and gyromagnetic factors g(2{sup +}), and the available experimental data in the parent and daughter even-even nuclei. In the present work, the required nuclear transition matrix elements are calculated in the Majorana neutrino mass mechanism using the same set of intrinsic wave functions as used to study the two neutrino positron double-{beta} decay modes. Limits on effective light neutrino mass <m{sub {nu}}> and effective heavy neutrino mass <M{sub N}> are extracted from the observed limits on half-lives T{sub 1/2}{sup 0{nu}}(0{sup +}{yields}0{sup +}) of ({beta}{sup +}{beta}{sup +}){sub 0{nu}} and ({epsilon}{beta}{sup +}){sub 0{nu}} modes. We also investigate the effect of quadrupolar correlations vis-a-vis deformation on nuclear transition matrix elements (NTMEs) required to study the ({beta}{sup +}{beta}{sup +}){sub 0{nu}} and ({epsilon}{beta}{sup +}){sub 0{nu}} modes.

73 NUCLEAR PHYSICS AND RADIATION PHYSICS↗

SU-F-T-44: A Comparison of the Pre-Plan, Intra-Operative Plan, and Post-Implant Dosimetry for a Prostate Implant Case Using Prefabricated Linear Polymer-Encapsulated Pd-103

Purpose: To investigate the reproducibility and limitations of Pd-103 prostate brachytherapy using fixed length linear sources (CivaString). Methods: An LDR prostate brachytherapy case which was preplanned on MR images with prefabricated linear polymer-encapsulated Pd-103 sources (CivaString) was studied and compared with ultrasound based intra-operative planning and CT based post-implant dosimetry. We evaluated the following parameters among the three studies: prostate geometry (volume and cross sectional area), needle position and alignment deviations, and dosimetry parameters (D90). Results: The prostate volumes and axial cross sectional areas at center of prostate were measured as 41.8, 39.3 and 36.8 cc, and 14.9, 14.3, and 11.3 respectively on pre-plan MR, inter-op US, and post-implant CT studies. The deviation of prostate volumes and axial cross sectional areas measured on pre-planning MR and intra-operative US were within 5%. 17 out of 19 pre-planned needles were positioned within 5mm (the template grid size). One needle location was adjusted intra-operatively and another needle was removed due to proximity to urethra. The needle pathways were not always parallel to the trans-rectal probe due to the flexibility of CivaString. The angle of deviation was up to 10 degrees. Two pairs of needles were exchanged to better fit the length of prostate at the time of implant. This resulted in a prostate D90 of 153.8 Gy (124%) and 131.4 Gy (106.7%) for intra-op and PID respectively. Conclusion: Preplanning is a necessary part of implants performed with prefabricated linear polymer sources. However, as is often the case, there were real-time deviations from the pre-plan. Intra-op planning provides the ability conform to anatomy at the time of implant. Therefore, we propose to develop a systematic way to order extra strings of different length to provide the flexibility to perform intra-operative planning with fixed length strands.

60 APPLIED LIFE SCIENCES↗

BEDVH--A method for evaluating biologically effective dose volume histograms: Application to eye plaque brachytherapy implants

Purpose: A method is introduced to examine the influence of implant duration T, radionuclide, and radiobiological parameters on the biologically effective dose (BED) throughout the entire volume of regions of interest for episcleral brachytherapy using available radionuclides. This method is employed to evaluate a particular eye plaque brachytherapy implant in a radiobiological context. Methods: A reference eye geometry and 16 mm COMS eye plaque loaded with {sup 103}Pd, {sup 125}I, or {sup 131}Cs sources were examined with dose distributions accounting for plaque heterogeneities. For a standardized 7 day implant, doses to 90% of the tumor volume ( {sub TUMOR}D{sub 90}) and 10% of the organ at risk volumes ( {sub OAR}D{sub 10}) were calculated. The BED equation from Dale and Jones and published {alpha}/{beta} and {mu} parameters were incorporated with dose volume histograms (DVHs) for various T values such as T = 7 days (i.e., {sub TUMOR} {sup 7}BED{sub 10} and {sub OAR} {sup 7}BED{sub 10}). By calculating BED throughout the volumes, biologically effective dose volume histograms (BEDVHs) were developed for tumor and OARs. Influence of T, radionuclide choice, and radiobiological parameters on {sub TUMOR}BEDVH and {sub OAR}BEDVH were examined. The nominal dose was scaled for shorter implants to achieve biological equivalence. Results: {sub TUMOR}D{sub 90} values were 102, 112, and 110 Gy for {sup 103}Pd, {sup 125}I, and {sup 131}Cs, respectively. Corresponding {sub TUMOR} {sup 7}BED{sub 10} values were 124, 140, and 138 Gy, respectively. As T decreased from 7 to 0.01 days, the isobiologically effective prescription dose decreased by a factor of three. As expected, {sub TUMOR} {sup 7}BEDVH did not significantly change as a function of radionuclide half-life but varied by 10% due to radionuclide dose distribution. Variations in reported radiobiological parameters caused {sub TUMOR} {sup 7}BED{sub 10} to deviate by up to 46%. Over the range of {sub OAR}{alpha}/{beta} values, {sub OAR} {sup 7}BED{sub 10} varied by up to 41%, 3.1%, and 1.4% for the lens, optic nerve, and lacrimal gland, respectively. Conclusions: BEDVH permits evaluation of the relative biological effectiveness for brachytherapy implants. For eye plaques, {sub TUMOR}BEDVH and {sub OAR}BEDVH were sensitive to implant duration, which may be manipulated to affect outcomes.

61 RADIATION PROTECTION AND DOSIMETRY↗